Stocks of Opko Health Inc (NASDAQ:OPK) traded higher last session on Wall Street, up 1.29% to $1.29.
OPK stock price is now 0.28 away from the 50-day moving average and Apr 30 AMC away from the 200-day moving average. The market capitalization of the company currently stands at $1.02B.
On June 29, 2023, Barrington Research Upgraded its previous ‘Mkt Perform’ rating to ‘Outperform’ on the stock keeping its target price maintained at $2, while ‘H.C. Wainwright’ rates the stock as ‘Buy’
In other news, FROST PHILLIP MD ET AL, CEO & Chairman bought 125,000 shares of the company’s stock on Apr 10 ’25. The stock was bought for $169,712 at an average price of $1.36. Upon completion of the transaction, the CEO & Chairman now directly owns 214,001,448 shares in the company, valued at $276.06 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 08 ’25, CEO & Chairman FROST PHILLIP MD ET AL bought 125,000 shares of the business’s stock. A total of $184,650 was incurred on buying the stock at an average price of $1.48. This leaves the insider owning 213,876,448 shares of the company worth $275.9 million. A total of 55.84% of the company’s stock is owned by insiders.
During the past 12 months, Opko Health Inc has had a low of $1.19 and a high of $2.04. The fifty day moving average price for OPK is $1.351 and a two-hundred day moving average price translates $1.52405 for the stock.
The net profit margin was -5.66% and return on equity was -3.04% for OPK.
